Fructus mume Extracts Alleviate Diarrhea in Breast Cancer Patients Receiving the Combination Therapy of Lapatinib and Capecitabine
Lapatinib and capecitabine have been widely used in the therapy of breast cancer. However, long-term use of lapatinib and capecitabine often causes the most common side effect diarrhea, which limit the medicine use. Fructus mume (F. mume) has been proved to be effective to treat chronic diarrhea wit...
Saved in:
Main Authors: | Hua Xing (Author), Lirong Zhang (Author), Jinshu Ma (Author), Zhen Liu (Author), Changlong Song (Author), Yuxia Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic toxicity in HER-2(+) breast cancer patient under treatment with capecitabine and lapatinib
by: Elia Romero Carreño, et al.
Published: (2016) -
Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa-tients with HER2+ breast cancer and central nervous system metastases
by: A. S. Kolbin, et al.
Published: (2018) -
Fructus mume aqueous extract's antibacterial effect on multispecies biofilm / Afzan Adilah Ayoub, Gary Shun-Pan Cheung
by: Ayoub, Afzan Adilah, et al.
Published: (2022) -
Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology
by: Yatian Yang, et al.
Published: (2023) -
Multi-component pharmacokinetic study of prunus mume fructus extract after oral administration in rats using UPLC-MS/MS
by: Yameng Zhu, et al.
Published: (2022)